Cargando…
Radiotherapy plays an important role in improving the survival outcome in patients with T1–2N1M0 breast cancer – a joint analysis of 4262 real world cases from two institutions
BACKGROUND: To compare the survival outcomes between breast-conserving surgery (BCS) and modified radical mastectomy (MRM), and to investigate the role of radiotherapy (RT) in patients with pT1–2N1M0 breast cancer. METHODS: A total of 4262 women with T1–2N1M0 breast cancer treated at two institution...
Autores principales: | Sun, Guang-Yi, Wen, Ge, Zhang, Yu-Jing, Tang, Yu, Jing, Hao, Wang, Jian-Yang, Zhang, Jiang-Hu, Yang, Yong, Zhao, Xu-Ran, Chen, Si-Ye, Jin, Jing, Song, Yong-Wen, Liu, Yue-Ping, Fang, Hui, Ren, Hua, Tang, Yuan, Qi, Shu-Nan, Li, Ning, Chen, Bo, Lu, Ning-Ning, Wang, Shu-Lian, Li, Ye-Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691055/ https://www.ncbi.nlm.nih.gov/pubmed/33243177 http://dx.doi.org/10.1186/s12885-020-07646-y |
Ejemplares similares
-
Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions
por: Sun, Guang-Yi, et al.
Publicado: (2022) -
Timing of Chemotherapy and Radiotherapy Following Breast-Conserving Surgery for Early-Stage Breast Cancer: A Retrospective Analysis
por: Chen, Si-Ye, et al.
Publicado: (2020) -
Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy
por: Sun, Guang-Yi, et al.
Publicado: (2021) -
Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial
por: Song, Yu-Chun, et al.
Publicado: (2021) -
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer
por: Yang, Jing, et al.
Publicado: (2021)